ArticlePharmaceutics2025
In Vivo Iterative Adjuvant Screening Identifies an Intranasal Vaccine Formulation for Elicitation of Protective Mucosal Immune Responses Against SARS-CoV-2.
Yang Jiao, Sara H Mahmoud, Chengjin Ye, Yuan Luo, Wei-Chiao Huang, Qinzhe Li, Shiqi Zhou, Yiting Song, Moriya Tsuji, Luis Martinez-Sobrido and 1 more
Abstract read
In one paragraphArticle in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Yang JiaoDepartment of Biomedical Engineering, State University of New York at Buffalo, Buffalo, NY 14260, USA.
Sara H MahmoudHost-Pathogen Interactions (HPI) and Disease Intervention and Prevention (DIP) Programs, Texas Biomedical Research Institute, San Antonio, TX 78227, USA.ORCID 0000-0002-1011-5608 Chengjin YeHost-Pathogen Interactions (HPI) and Disease Intervention and Prevention (DIP) Programs, Texas Biomedical Research Institute, San Antonio, TX 78227, USA.
Yuan LuoDepartment of Biomedical Engineering, State University of New York at Buffalo, Buffalo, NY 14260, USA.
Wei-Chiao HuangDepartment of Biomedical Engineering, State University of New York at Buffalo, Buffalo, NY 14260, USA.
Qinzhe LiDepartment of Biomedical Engineering, State University of New York at Buffalo, Buffalo, NY 14260, USA.
Shiqi ZhouDepartment of Biomedical Engineering, State University of New York at Buffalo, Buffalo, NY 14260, USA.ORCID 0000-0002-0530-9512 Yiting SongDepartment of Biomedical Engineering, State University of New York at Buffalo, Buffalo, NY 14260, USA.
Moriya TsujiAaron Diamond AIDS Research Center, Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA.ORCID 0000-0001-8587-277X Luis Martinez-SobridoHost-Pathogen Interactions (HPI) and Disease Intervention and Prevention (DIP) Programs, Texas Biomedical Research Institute, San Antonio, TX 78227, USA.ORCID 0000-0001-7084-0804 Jonathan F LovellDepartment of Biomedical Engineering, State University of New York at Buffalo, Buffalo, NY 14260, USA.ORCID 0000-0002-9052-884X Funding
NIH HHS 1R43AI165089
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
adjuvantsintranasalliposomesRBDSARS-CoV-2vaccines
Identifiers
PMID41304760
PMCPMC12655344
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390